Edwards Lifesciences EW Rest of World — Cost of Sales

Other segment segments

Similar metrics at other companies

AOSRest of World — Cost of products sold

$128.2M-10.2%

HAYWEurope & Rest of World — Cost of Sales

$21.49M-2.2%

BCORest of World — Cost of revenues

$151.7M+6.9%

BCORest of World — Selling, general and administrative expenses

$19.1M+42.5%

BCORest of World — Other cost of revenues segment items

$96.3M+3.7%

MAG

MAGNRest Of World — Operating Expenses

$327M+0.3%

Questions, answered.

What is Edwards Lifesciences's rest of world — cost of sales?

Edwards Lifesciences (EW) reported rest of world — cost of sales of $47.6M in Q1 2026.

How has Edwards Lifesciences's rest of world — cost of sales changed year-over-year?

Edwards Lifesciences's rest of world — cost of sales increased by 19.6% year-over-year, from $39.8M to $47.6M.

What is the long-term trend for Edwards Lifesciences's rest of world — cost of sales?

Over 3 years (2022 to 2025), Edwards Lifesciences's rest of world — cost of sales has grown at a 13.0% compound annual growth rate (CAGR), from $118.2M to $170.6M.

What does rest of world — cost of sales mean?

This metric captures the direct costs associated with manufacturing, shipping, and distributing medical devices sold within the Rest of World segment. It includes raw materials, direct labor, and overhead costs specifically allocated to products sold in these international regions. Monitoring this helps evaluate the efficiency of the supply chain and production logistics for non-core geographic markets.